INSTEEL INDUSTRIES INC Stock Compensation Disclosure
(9) Stock-Based Compensation
Under our equity incentive plan, employees and directors may be granted stock options, restricted stock, restricted stock units and performance awards. Effective February 11, 2025, the shareholders of the Company approved the 2025 Equity Incentive Plan of Insteel Industries Inc. (the “2025 Plan”), which authorizes the issuance of up to 800,000 shares of our common stock, plus any shares remaining available for grant under the 2015 Equity Incentive Plan of Insteel Industries Inc. (as amended, the “2015 Plan”) as of the effective date of the 2025 Plan and any shares subject to an award granted under the 2015 Plan which are forfeited, cancelled, terminated, lapsed or expired without the issuance of shares. The 2025 Plan, which expires on February 10, 2035, replaces the 2015 Plan, which expired on February 17, 2025. As of September 27, 2025, there were 905,000 shares of our common stock available for future grants under the 2025 Plan, which is our only active equity incentive plan.
Stock option awards. Under our equity incentive plan, employees and directors may be granted options to purchase shares of common stock at the fair market value on the date of the grant. Options granted under the plan generally vest over years and expire years from the date of the grant. Compensation expense associated with stock options was $1.4 million in 2025, $1.4 million in 2024 and $1.0 million in 2023. As of September 27, 2025, there was $712,000 of unrecognized compensation cost related to unvested options which is expected to be recognized over a weighted average period of 2.20 years.
The fair value of each option award granted is estimated on the date of grant using a Monte Carlo valuation model. The weighted-average estimated fair values of stock options granted during 2025, 2024 and 2023 were $12.70, $13.01 and $13.27 per share, respectively, based on the following weighted-average assumptions:
|
Year Ended |
||||||||||||
|
September 27, |
September 28, |
September 30, |
||||||||||
|
2025 |
2024 |
2023 |
||||||||||
|
Expected term (in years) |
4.62 | 4.20 | 4.35 | |||||||||
|
Risk-free interest rate |
4.29 | % | 4.12 | % | 4.27 | % | ||||||
|
Expected volatility |
39.32 | % | 44.83 | % | 49.61 | % | ||||||
|
Expected dividend yield |
0.38 | % | 0.36 | % | 0.40 | % | ||||||
The assumptions utilized in the Monte Carlo valuation model are evaluated and revised, as necessary, to reflect market conditions and actual historical experience. The expected term for options was based on the results of a Monte Carlo simulation model, using the model’s estimated fair value as an input to the Black-Scholes-Merton model, and then solving for the expected term. The risk-free interest rate for periods within the contractual life of the option was based on the U.S. Treasury yield curve in effect at the time of the grant. The expected volatility was derived using a term structure based on historical volatility and the volatility implied by exchange-traded options on our common stock. The dividend yield was calculated based on our annual dividend as of the option grant date.
The following table summarizes stock option activity:
|
Contractual |
Aggregate |
|||||||||||||||
|
Options |
Weighted |
Term - Weighted |
Intrinsic |
|||||||||||||
|
Outstanding |
Average |
Average |
Value |
|||||||||||||
|
(in thousands) |
Exercise Price |
(in years) |
(in thousands) |
|||||||||||||
|
Outstanding at October 1, 2022 |
365 | $ | 30.00 | |||||||||||||
|
Granted |
97 | 30.63 | ||||||||||||||
|
Exercised |
(32 | ) | 21.29 | $ | 350 | |||||||||||
|
Forfeited |
(19 | ) | 33.22 | |||||||||||||
|
Outstanding at September 30, 2023 |
411 | 30.68 | ||||||||||||||
|
Granted |
101 | 33.22 | ||||||||||||||
|
Exercised |
(38 | ) | 30.79 | 194 | ||||||||||||
|
Forfeited |
(8 | ) | 41.86 | |||||||||||||
|
Outstanding at September 28, 2024 |
466 | 31.03 | ||||||||||||||
|
Granted |
112 | 33.63 | ||||||||||||||
|
Exercised |
(54 | ) | 26.95 | 568 | ||||||||||||
|
Outstanding at September 27, 2025 |
524 | 32.01 | 6.89 | 3,549 | ||||||||||||
|
Vested and anticipated to vest in the future at September 27, 2025 |
512 | 31.98 | 6.84 | 3,490 | ||||||||||||
|
Exercisable at September 27, 2025 |
314 | 31.30 | 5.46 | 2,409 | ||||||||||||
Stock option exercises include “net exercises” for which the optionee received shares of common stock equal to the intrinsic value of the options (fair market value of common stock on the date of exercise less exercise price) reduced by any applicable withholding taxes.
Restricted stock units. Restricted stock units (“RSUs”) granted under our equity incentive plan are valued based upon the fair market value on the date of the grant and provide for a dividend equivalent payment which is included in compensation expense. The vesting period for RSUs is generally year from the date of the grant for RSUs granted to directors and years from the date of the grant for RSUs granted to employees. RSUs do not have voting rights. RSU grants and compensation expense are as follows:
| Year Ended | ||||||||||||
|
September 27, |
September 28, |
September 30, |
||||||||||
|
(In thousands) |
2025 |
2024 |
2023 |
|||||||||
|
Restricted stock unit grants: |
||||||||||||
|
Units |
68 | 52 | 57 | |||||||||
|
Market value |
$ | 2,230 | $ | 1,769 | $ | 1,738 | ||||||
|
Compensation expense |
2,070 | 1,730 | 1,392 | |||||||||
As of September 27, 2025, there was $1.3 million of unrecognized compensation cost related to unvested RSUs which is expected to be recognized over a weighted average period of 1.59 years.
The following table summarizes RSU activity:
|
Weighted |
Aggregate |
|||||||||||
|
Restricted |
Average |
Intrinsic |
||||||||||
|
Stock Units |
Grant Date |
Value |
||||||||||
|
(Unit amounts in thousands) |
Outstanding |
Fair Value |
(in thousands) |
|||||||||
|
Balance, October 1, 2022 |
120 | $ | 29.88 | |||||||||
|
Granted |
57 | 30.53 | ||||||||||
|
Forfeited |
(10 | ) | 30.36 | |||||||||
|
Vested |
(62 | ) | 25.71 | $ | 1,911 | |||||||
|
Balance, September 30, 2023 |
105 | 35.07 | ||||||||||
|
Granted |
52 | 33.56 | ||||||||||
|
Vested |
(38 | ) | 33.02 | 1,322 | ||||||||
|
Balance, September 28, 2024 |
119 | 32.96 | ||||||||||
|
Granted |
68 | 32.77 | ||||||||||
|
Vested |
(40 | ) | 35.05 | 1,323 | ||||||||
|
Balance, September 27, 2025 |
147 | 32.31 | ||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Oct 23, 2025 | Showing above |
| 2024 | Oct 24, 2024 | |
| 2023 | Oct 26, 2023 | |
| 2022 | Oct 27, 2022 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.